These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6612853)

  • 21. The relative efficacy of erythromycin (ilotycin) and of penicillin in the treatment of pneumococcal lobar pneumonia.
    AUSTRIAN R; ROSENBLUM R
    Am J Med Sci; 1953 Nov; 226(5):487-90. PubMed ID: 13104398
    [No Abstract]   [Full Text] [Related]  

  • 22. [Initial treatment of acute localized pneumonia. The problem of pneumococci resistant to erythromycin].
    Brun-Ney D; Malbrunot C; Rouveix E; Sirieix ME; Dournon E; Dorra M
    Presse Med; 1986 May; 15(21):982. PubMed ID: 2942862
    [No Abstract]   [Full Text] [Related]  

  • 23. [Fatal infection with chloramphenicol resistant pneumococcus].
    Margaliot S; Reichert N; Rubinstein E
    Harefuah; 1982 Mar; 102(5):197-8. PubMed ID: 7117946
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and medicinal cost-effect assessment of effectiveness of empirical therapy of extra-hospital pneumonia in hospital setting].
    Tsoĭ AN; Arkhipov VV; Antonovskiĭ IuA; Shoker S; Kukes VG
    Klin Med (Mosk); 2002; 80(11):37-41. PubMed ID: 12516339
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
    Lee WK; Young BW
    J Antimicrob Chemother; 2005 Sep; 56(3):603-5. PubMed ID: 16040621
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pneumococcal pneumonia: epidemiology, therapy, immunoprophylaxis].
    Gartmann J
    Schweiz Med Wochenschr; 1980 Aug; 110(35):1258-65. PubMed ID: 6903401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Learning in the real world.
    Varga DW
    J Ky Med Assoc; 1993 May; 91(5):203. PubMed ID: 8509688
    [No Abstract]   [Full Text] [Related]  

  • 28. Heading off antibiotic resistance.
    Woolard S; Kenkel D
    Adv Nurse Pract; 2001 Apr; 9(4):28. PubMed ID: 12420432
    [No Abstract]   [Full Text] [Related]  

  • 29. Pneumococcal pneumonia in adults treated at University of Kentucky Medical Center, 1995-1998: implications of pathogen resistance.
    Greenberg RN; Martin E
    Clin Infect Dis; 1999 May; 28(5):1160-2. PubMed ID: 10452654
    [No Abstract]   [Full Text] [Related]  

  • 30. [Acute localized pneumopathies. Should macrolides always be prescribed initially?].
    Dautzenberg B; Gallinari C; Axler O; Moreau A; Nguyen J; Jarlier V; Fievet MH
    Presse Med; 1985 Nov; 14(37):1928. PubMed ID: 2933697
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lower respiratory tract infections in the child. The microbiologist's point of view].
    Demachy MC
    Presse Med; 2002 Nov; 31(37 Pt 2):S12-3; discussion S15. PubMed ID: 12489327
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythromycin in the treatment of pneumococcal pneumonia.
    BACON AE
    Del State Med J; 1953 Oct; 25(10):300-4. PubMed ID: 13094978
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and microbiological studies on macrocycline].
    Parnas J; Pietra A; Pleszczyńska E
    Pol Tyg Lek; 1967 Jul; 22(20):1162-5. PubMed ID: 4862917
    [No Abstract]   [Full Text] [Related]  

  • 34. Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia.
    Anderson KB; Tan JS; File TM; DiPersio JR; Willey BM; Low DE
    Clin Infect Dis; 2003 Aug; 37(3):376-81. PubMed ID: 12884162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current use of penicillin in community-acquired pneumococcal pneumonias].
    Gaztelurrutia L; Zalacaín R; Rubio G; Hernández JL; Urra E; Hernández M; Garea C; Barrón J
    Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):17-20. PubMed ID: 8155749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic options for pneumococcal pneumonia in Turkey.
    Oncu S; Erdem H; Pahsa A
    Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of pneumococcal pneumonia with erythromycin and carbomycin (magnamycin).
    BUNN PA; COOK E
    AMA Arch Intern Med; 1953 Sep; 92(3):333-40. PubMed ID: 13091455
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
    Aspa J; Rajas O; Rodríguez de Castro F; Blanquer J; Zalacain R; Fenoll A; de Celis R; Vargas A; Rodríguez Salvanés F; España PP; Rello J; Torres A;
    Clin Infect Dis; 2004 Mar; 38(6):787-98. PubMed ID: 14999620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumonia due to resistant Streptococcus pneumoniae.
    Täuber MG
    Schweiz Med Wochenschr; 2000 Dec; 130(49):1873-9. PubMed ID: 11153392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.